• SENSEX 74,315.61
    1,533.72 (+2.11%)
  • BANKNIFTY 55,810.50
    494.50 (+0.89%)
  • Reliance Industries
    1,223.30 1,611.20(%)
  • NSE
    1,777.00 1,878.00(%)
  • TCS
    2,386.70 3,336.70(%)
  • HCL Technologies
    1,376.00 1,770.00(%)
  • HDFC Bank
    728.55 1,020.35(%)
  • Infosys
    1,126.40 1,727.85(%)
  • Indian Hotels Co
    752.50 757.10(%)
  • Gallantt Ispat L
    648.45 946.70(%)
  • ICICI Bank
    1,395.00 1,479.90(%)
  • NMDC
    70.56 70.15(%)
  • Billionbrains
    200.85 227.00(%)
  • Axis Bank
    1,294.40 1,418.30(%)
  • Netweb Technol.
    4,666.00 2,942.45(%)
  • Bajaj Finance
    975.00 1,177.60(%)
  • HDB FINANC SER
    536.65 536.65(%)
  • Bharti Airtel
    1,871.20 2,174.70(%)
  • SS Retail
    741.55 603.00(%)
  • Eternal
    324.35 368.40(%)
  • Kotak Mah. Bank
    448.85 452.98(%)
  • MV Electrosystems
    918.00 510.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Ajanta Pharma Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 13504.0
  • ISIN : INE031B01049
3,359.40 60 (1.83%)
  • As on 15 Oct 2026 (EOD)

  • Today’s Low

    3,313.70

  • Today’s High

    3,387.70

  • Open

    3,330.00

  • Perv Close

    3,299.00

  • 52W Low

    2,382.00

  • 52W High

    3,796.00

Key Indicators

  • P/E(TTM)

    41.69

  • Mar.Cap (₹Cr.)

    41,978.73

  • Div & Yield %

    0.84

  • Book Value(₹)

    337.99

  • Debt-Equity Ratio

    1.83

  • AGM Date

    15-Oct-2026

  • EPS

    80.61

  • P/E Ratio

    41.69

Financials Ratios

  • Debt-Equity Ratio

    0.01

  • Mar.Cap (₹Cr.)

    41,978.73

  • RONW (%)

    23.47

  • ROCE (%)

    31.59

Score Board

  • Equity (₹ in Cr.)

    24.99

  • BV (₹)

    338.00

  • Sales( ₹ in Cr.)

    4,845.92

  • NP (in Cr.)

    941.57

  • NP Var(%)

    4.0

  • Div%

    1400.0

  • CPS (₹)

    88.90

  • EPS (₹)

    75.40

  • Traded Value (₹ in Lakhs)

    41,989.36

  • 52 Week High

    3,796.00

  • 52 Week Low

    2,382.00

  • Price BSE

    3360.0

  • Price NSE

    3,359.00

  • Market Capital( in Cr.)

    41,989.36

  • P/C Ratio

    37.80

  • P/E Ratio

    44.60

  • Price Vs.BV

    75.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 4,845.92 4,322.04 3,971.12 3,411.27 3,140.64 2,718.59
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 4,845.92 4,322.04 3,971.12 3,411.27 3,140.64 2,718.59
Other Income 204.40 119.87 116.48 132.75 139.73 103.57
Stock Adjustments 57.32 18.58 22.17 21.99 56.60 74.60
Total Income 5,107.64 4,460.49 4,109.77 3,566.01 3,336.97 2,896.76
EXPENDITURE :            
Raw Materials 1,134.58 1,030.60 1,101.59 1,027.40 889.16 804.68
Power and Fuel Cost 73.17 70.22 66.44 65.53 54.09 43.42
Employee Cost 1,194.05 1,010.90 834.16 720.41 585.87 498.11
Other Manufacturing Expenses 223.18 198.94 168.11 185.50 169.95 119.25
Selling and Administration Expenses 838.98 695.46 587.02 602.95 512.46 324.31
Miscellaneous Expenses 241.29 129.78 116.54 132.19 94.82 86.51
Employee Benefit Expenses 1,194.05 1,010.90 834.16 720.41 585.87 498.11
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 3,705.25 3,135.90 2,873.86 2,733.98 2,306.35 1,876.28
Operating Profit 1,402.39 1,324.59 1,235.91 832.03 1,030.62 1,020.48
Interest 2.59 4.60 6.80 5.23 9.12 6.90
Gross Profit 1,399.80 1,319.99 1,229.11 826.80 1,021.50 1,013.58
Depreciation 168.77 139.93 132.16 126.95 120.96 111.49
Profit Before Tax 1,231.03 1,180.06 1,096.95 699.85 900.54 902.09
Current Tax 276.61 258.03 280.56 141.08 171.17 216.68
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 7.60 5.14 9.15 0.05 9.51 9.77
Reported Net Profit 946.82 916.89 807.24 558.72 719.86 675.64
Extraordinary Items 5.25 10.88 11.11 12.87 -0.62 2.91
Adjusted Net Profit 941.57 906.01 796.13 545.85 720.48 672.73
Adjustment below Net Profit 0.00 -213.11 -0.92 -74.72 -68.50 -32.42
P & L Balance brought forward 3,607.47 3,253.44 3,089.29 2,694.98 2,125.83 1,565.51
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 349.82 349.75 642.17 89.69 82.21 82.90
P & L Balance carried down 4,204.47 3,607.47 3,253.44 3,089.29 2,694.98 2,125.83
Dividend 349.82 349.75 642.17 89.69 82.21 82.90
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 1,400.00 1,400.00 2,550.00 350.00 475.00 475.00
Dividend Per Share(Rs) 28.00 28.00 51.00 7.00 9.50 9.50
Earnings Per Share-Unit Curr 75.53 73.15 63.89 44.22 83.85 77.70
Earnings Per Share(Adj)-Unit Curr 75.53 73.15 63.89 44.22 55.90 51.80
Book Value 336.94 289.21 270.17 256.94 369.15 331.80
Book Value(Adj)-Unit Curr 336.94 289.21 270.17 256.94 246.10 221.20

Shareholding Pattern

  • Promoter Group

    63.47%

  • Public Share Holding

    36.53%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 12,588,393 10.07 12,588,393 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 66,725,384 53.40 66,725,384 7
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 79,313,777 63.47 79,313,777 8
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 55 0.00 55 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 9,530,731 7.63 9,530,731 273
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 4,477,877 3.58 4,477,877 19
Mutual Funds / UTI 22,425,500 17.95 22,425,500 34
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 517,533 0.41 517,533 26
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 36,951,696 29.57 36,951,696 353
2] Non Institution
Bodies Corporate 226,988 0.18 226,613 527
Clearing Members 16,978 0.01 16,978 25
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 361,705 0.29 361,705 2,402
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 161,330 0.13 161,330 1,075
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 794,098 0.64 794,098 5
Individuals holding nominal share capital up to Rs. 1 lakh 6,959,786 5.57 6,831,909 57,462
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 1,272 0.00 1,272 4
Others 137,996 0.11 137,996 3
Sub Total 8,693,551 6.96 8,565,299 61,562
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 124,959,024 100.00 124,830,772 61,923

Company Background

Ajanta Pharma LtdPharmaceuticals - Indian - Formulations

  • Ajanta Pharma Ltd
  • BSE Code : 13504.0
  • ISIN : INE031B01049

  • Incorporation Year

    1979

  • Registered Office

    Ajanta House
    Charkop Kandivli (W), Mumbai,
    Maharashtra-400067

  • Telephone

    91-22-66061000/1204/1203

  • FAX

    91-22-66061200/1300

  • Chairman

    Mannalal B Agrawal

  • Managing Director

  • Company Secretary

    Gaurang Shah

  • Auditor

    B S R & Co LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Ajanta Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Ajanta Pharma 3,360.25 5,050.32 4,845.92 41.69 30.64
Abbott India 26,068.45 7,217.19 6,929.05 34.31 43.78
Astrazeneca Phar 5,922.60 2,304.07 2,275.58 87.29 27.86
Glaxosmi. Pharma 2,523.00 3,932.76 3,790.20 40.30 58.17
Novartis India 1,937.30 393.10 354.33 48.92 15.94
Cipla 1,333.70 20,102.60 18,979.95 35.05 13.88
Bliss GVS Pharma 655.95 773.53 729.81 60.96 12.51
Amrutanjan Healt 506.40 520.13 502.55 27.12 24.16
Fermenta Biotec. 486.65 474.15 450.25 22.72 18.77
Guj. Themis Bio. 370.70 168.25 165.82 99.12 18.05
Ambalal Sarabhai 38.15 19.52 3.94 70.65 6.77